PurpleLab Launches Self-Service Campaign Measurement Platform

PurpleLab, has launched a new end-to-end campaign measurement solution designed to give healthcare advertisers direct, self-service access to performance insights.

The solution expands PurpleLab’s HealthNexus platform and is also available via standalone APIs and custom measurement services. It seeks to enable advertisers to manage the full measurement lifecycle—from exposure data ingestion through outcomes analysis and reporting—without relying on external analytics teams. Results can be generated on demand through APIs or auto-produced insight reports.

Healthcare marketers have often faced delays and limited visibility in campaign analytics, challenges intensified by direct-to-consumer regulations and fragmented identity signals. PurpleLab says the new platform is intended to address those gaps by unifying media exposure and de-identified health outcomes in a single workflow.

Built on real-world, de-identified health data, the measurement suite allows advertisers to evaluate how campaigns influence prescribing behavior and to optimise activity during live campaigns as well as post-campaign. Measurement is embedded directly into the activation process, creating what the company describes as a continuous feedback loop across digital, TV, and programmatic channels.

With the launch, PurpleLab is positioning the platform as an alternative to point-solution measurement tools that focus on either media or claims data alone. Each report provides visibility into audience match rates, control group logic, and downstream outcomes, with an interface designed for use without analyst support.

“Advertisers shouldn’t have to choose between speed and trust,” said Scott Ronay, general manager of advertising at PurpleLab. “As the industry moves toward real-time optimisation, self-service measurement is becoming essential for marketers who need both agility and data integrity.”

PurpleLab said it plans to expand its measurement APIs in 2026, including healthcare professional measurement enhancements and procedure-level insights. All methodologies supporting the platform are compliant with HIPAA, IAB, and NAI standards, reflecting a privacy-first approach to healthcare advertising measurement.

solli’s Final Thought

The launch also reflects a broader shift underway across the pharma media and advertising ecosystem. As marketers demand faster feedback and greater transparency, measurement is increasingly moving closer to activation rather than remaining a post-campaign exercise.

Self-service analytics, tighter integration between media and outcomes, and privacy-compliant use of real-world data point to a future in which pharma media platforms are expected not only to distribute messages, but to provide clearer, near real-time evidence of impact—reshaping how value is defined, priced, and optimised across the industry.

Read the full press release here.